Goldman Sachs Group Inc Abbott Laboratories Transaction History

Goldman Sachs Group Inc

$605 Billion
Q3 2024

A detailed history of Goldman Sachs Group Inc transactions in Abbott Laboratories stock. As of the latest transaction made, Goldman Sachs Group Inc holds 10,682,835 shares of ABT stock, worth $1.22 Billion. This represents 0.2% of its overall portfolio holdings.

Number of Shares

10,682,835

Previous 9,563,318 11.71%

Holding current value

$1.22 Billion

Previous $994 Million 22.56%

% of portfolio

0.2%

Previous 0.17%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$100.07 - $118.13 $112 Million - $132 Million	1,119,517 Added 11.71%	10,682,835 $1.22 Billion
Q2 2024 Aug 13, 2024	SELL	$100.73 - $112.44 $109 Million - $122 Million	-1,082,041 Reduced 10.16%	9,563,318 $994 Million
Q1 2024 May 15, 2024	SELL	$109.52 - $120.96 $83.7 Million - $92.4 Million	-764,081 Reduced 6.7%	10,645,359 $1.21 Billion
Q4 2023 Feb 13, 2024	BUY	$90.19 - $110.4 $236 Million - $289 Million	2,613,832 Added 29.72%	11,409,440 $1.26 Billion
Q3 2023 May 14, 2024	SELL	$95.53 - $114.62 $250 Million - $300 Million	-2,613,832 Reduced 22.91%	8,795,608 $852 Million
Q3 2023 Nov 14, 2023	BUY	$95.53 - $114.62 $10.2 Million - $12.3 Million	107,048 Added 1.23%	8,795,608 $852 Million
Q2 2023 May 14, 2024	BUY	$100.78 - $112.29 $22.1 Million - $24.7 Million	219,729 Added 2.59%	8,688,560 $947 Million
Q2 2023 Aug 14, 2023	BUY	$100.78 - $112.29 $22.1 Million - $24.7 Million	219,729 Added 2.59%	8,688,560 $947 Million
Q1 2023 May 14, 2024	SELL	$96.86 - $114.01 $12 Million - $14.2 Million	-124,374 Reduced 1.45%	8,468,831 $858 Million
Q1 2023 May 11, 2023	SELL	$96.86 - $114.01 $12 Million - $14.2 Million	-124,374 Reduced 1.45%	8,468,831 $858 Million
Q4 2022 May 14, 2024	SELL	$95.06 - $111.52 $47.4 Million - $55.6 Million	-498,445 Reduced 5.48%	8,593,205 $944 Million
Q4 2022 Feb 13, 2023	SELL	$95.06 - $111.52 $47.4 Million - $55.6 Million	-498,445 Reduced 5.48%	8,593,205 $944 Million
Q3 2022 May 14, 2024	BUY	$96.76 - $112.03 $113 Million - $130 Million	1,164,821 Added 14.69%	9,091,650 $880 Million
Q3 2022 Nov 10, 2022	BUY	$96.76 - $112.03 $113 Million - $130 Million	1,164,821 Added 14.69%	9,091,650 $880 Million
Q2 2022 May 14, 2024	SELL	$102.07 - $123.37 $355 Million - $430 Million	-3,482,611 Reduced 30.52%	7,926,829 $861 Million
Q2 2022 Aug 15, 2022	BUY	$102.07 - $123.37 $73 Million - $88.2 Million	714,750 Added 9.91%	7,926,829 $861 Million
Q1 2022 May 16, 2022	BUY	$114.02 - $139.04 $12.1 Million - $14.7 Million	105,829 Added 1.49%	7,212,079 $854 Million
Q4 2021 Feb 14, 2022	SELL	$115.53 - $141.46 $158 Million - $194 Million	-1,369,037 Reduced 16.15%	7,106,250 $1 Billion
Q3 2021 Nov 10, 2021	BUY	$116.66 - $129.06 $989 Million - $1.09 Billion	8,475,287 New	8,475,287 $1 Billion

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $200B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Account

Goldman Sachs Group Inc Abbott Laboratories Transaction History